Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients:...
Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study
About this item
Full title
Author / Creator
EOLO study group , Gonnelli, S , Caffarelli, C , Maggi, S , Guglielmi, G , Siviero, P , Rossi, S , Crepaldi, G and Nuti, R
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Although inhaled glucocorticoids (GCs) and beta(2) agonists are being more frequently prescribed in the management of chronic obstructive pulmonary disease (COPD), their role in the impairment of bone status and in fracture risk remains controversial. This study aimed to evaluate whether the dose of inhaled GCs and beta(2) agonists may independentl...
Alternative Titles
Full title
Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733979877
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733979877
Other Identifiers
E-ISSN
1432-0827
DOI
10.1007/s00223-010-9392-x
